0126Z0.KS SAMSUNG EPIS HOLDINGS | KR70126Z0002
Company Profile
Samsung Epis Holdings Co., Ltd., a biotechnology company, manage the portfolio of biopharmaceutical products. The company was founded in 2025 and is based in Incheon, South Korea.
Latest News
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
PR Newswire • 07/27/2026
Netflix Is Down 41% in 1 Year. Could the Sell-Off Be Nearing an End?
Motley Fool • 07/27/2026
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
PR Newswire • 07/27/2026
| Sector | Healthcare |
| Industry | Biotechnology |
| Website | https://www.samsungepisholdings.com/en/ |
| Market Cap | 9.75T |
| Enterprise-to-Revenue | 6.81 |
| Enterprise-to-EBITDA | 383.22 |
| Earnings Date | 10/23/2026 |
| Earnings Call Date | |
| Revenue Average | 454.00B |
| Revenue Low | 441.00B |
| Revenue High | 467.00B |